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a b s t r a c t
Atom transfer radical polymerization (ATRP) has been successfully employed to obtain a new derivative
of hyaluronic acid (HA) able to change its solubility as a function of external pH and then to be potentially
useful for intestinal release of bioactive molecules, included enzymes and proteins.
In particular, a macroinitiator has been prepared by linking 2-bromo-2-methypropionic acid (BMP) to
the amino groups of ethylenediamino derivative of tetrabutyl ammonium salt of HA (HA-TBA-EDA). This
macroinititor, named HA-TBA-EDA-BMP has been used for the ATRP of sodium methacrylate (MANa)
using a complex of Cu(I) and 2,2′-bipyridyl (Byp) as a catalyst.
The resulting copolymer, named HA-EDA-BMP-MANa, has been characterized by 1H NMR and size
exclusion chromatography (SEC) analyses. A turbidimetric analysis has showed its pH sensitive behavior,
being insoluble in simulated gastric fluid but soluble when pH increases more than 2.5. To confirm the
ability of HA-EDA-BMP-MANa in protecting peptides or proteins from denaturation in acidic medium,
-chymotrypsin has been chosen as a model of protein molecule and its activity has been evaluated after
entrapment into HA-EDA-BMP-MANa chains and treatment under simulated gastric conditions. Finally,
cell compatibility has been evaluated by performing a MTS assay on murine dermal fibroblasts cultured
with HA-EDA-BMP-MANa solutions.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
pH sensitive drug delivery systems represent a smart way for
drug administration since they are able to release loaded molecules
in response to pH gradient that exists between different sites of
the body. For instance, pH gradients between normal tissues and
some pathological sites, between the extracellular environment
and some cellular compartments and along the gastrointestinal (GI)
tract are well characterized (Felber et al., 2012).
In particular the pH difference between the stomach (pH 1–2
about) and the small intestine, jejunum and ileum (pH 6–7.5 about)
requires the use of pH sensitive carriers capable to protect, if nec-
essary, bioactive molecules from acid degradation and to release
them in the intestine in their active form.
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Especially peptides, proteins and nucleic acids easily undergo
inactivation in the stomach; this represents a serious issue since
these bioactive molecules are receiving an increasing interest for
the treatment of several pathologies, thanks also to the increased
availability of novel therapeutic molecules through the recombi-
nant DNA technology (Yun et al., 2013). On the other hand, oral
delivery is still the preferred route of drug administration since
it offers to patients less pain, greater convenience, higher compli-
ance, and reduced risk of cross-infection and needlestick injuries
(Florence and Jani, 1993; Chen and Langer, 1998).
Starting from pH sensitive polymers, gastro-resistant drug
delivery systems have been produced in the form of hydrogels
(Pitarresi et al., 2008), nanoparticles (Licciardi et al., 2013) and
microparticles (Licciardi et al., 2012). They can be also used as
coating of tablets or capsules.
The main characteristic of gastro-resistant polymers is the pres-
ence of carboxyl groups able to allow drug release as a function
of their deprotonation pH dependent. pH sensitive polymers can
be natural, like alginate or synthetic, like poly(methacrylic acid)
derivatives, as well as semisynthetic, like hydroxypropyl methyl-
cellulose phthalate.
0378-5173/$ – see front matter © 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.ijpharm.2013.09.005
Author's personal copy
C. Fiorica et al. / International Journal of Pharmaceutics 457 (2013) 150–157 151
Among natural polymers, hyaluronic acid (HA) possesses very
interesting biological properties indeed it has been extensively
employed for the production of drug delivery systems (Pitarresi
et al., 2007, 2010) and scaffolds for tissue engineering (Ji et al.,
2006). Being HA a linear polysaccharide consisting of alternating
disaccharide units of -1,4-d-glucuronic acid and -1,3-N-acetyl-
d-glucosamine, it contains one carboxylic group per repetitive unit
then it shows some pH sensitivity in aqueous environment, espe-
cially when it is crosslinked to produce drug delivery systems
like hydrogels and micro or nanoparticles. As example, recently
HA nanoparticles have been employed for the oral administration
of insulin (Han et al., 2012). Also the pH responsive behavior of
hyaluronic acid hydrogels has been reported for photocrosslinked
networks based on HA for the release of thrombin (Pitarresi et al.,
2004).
However, unlike other pH sensitive polymers, for example
Eudragit®, HA does not show a pronounced difference in solubil-
ity in aqueous media at different pH; this means that when pH is
1–2 (simulated gastric fluid) no precipitation of HA occurs. For this
reason HA cannot be exploited as gastro-resistant coating for solid
pharmaceutical forms.
With the aim to increase the number of carboxyl groups of
natural HA, thus obtaining an appropriate derivative capable of
changing its solubility in an aqueous environment as a function
of pH, we have performed atom transfer radical polymerization
(ATRP) of sodium methacrylate into a macroinitiator based on an
amino functionalized HA derivative.
Recently we have demonstrated that it is possible to produce
HA based “macroinitiators” by functionalizing HA or its ethylene-
diamino derivative (HA-EDA) with 2-bromo-2-methylpropionic
acid (BMP). These “multi functional macroinitiators” have been
employed for the ATRP of different molecules carrying vinyl
portions to allow the polymerization of poly(ethylene glycol)
methacrylate (PEGMA), butyl methacrylate (BUTMA) and N-
isopropylamide (NIPAM) on their side chains (Pitarresi et al., 2013).
Obtained results demonstrated that ATRP is more efficient starting
from the amino funzionalized HA, for this reason, in this work we
have used HA-EDA as initial material to perform ATRP of sodium
methacrylate.
The resulting copolymer, named HA-EDA-BMP-MANa, has been
characterized by 1H NMR and size exclusion chromatography (SEC)
ant its pH sensible behavior has been demonstrated by a turbidi-
metric analysis. -Chymotrypsin has been chosen as a model of
protein molecule, to verify the ability of HA-EDA-BMP-MANa to
protect proteins from degradation in acidic medium, like simulated
gastric fluid and an in vitro biological assay has been performed to
evaluate its cell compatibility.
2. Experimental
2.1. Materials and methods
All reagents were of analytical grade unless otherwise stated.
-Chymotrypsin from bovine pancreas, N-benzoyl-l-tyrosine
ethyl ester (BTEE), acetone, methanol, 1-ethyl-3-[3-(dimethy-
lamino)propyl]carbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), bis(4-nitrophenyl) carbonate
(4-NPBC), tetrabutylammonium hydroxide (TBA-OH), diethy-
lamine (DEA), 2-bromo-2-methylpropionic acid (BMP), sodium
methacrylate (MANa), copper bromide [Cu(I)Br], 2,2′-bipyridyl
(Bpy), deuterium oxide (D2O), were purchased from Sigma–Aldrich.
Hyaluronic acid (HA) having a low weight-average molecular
weight was prepared by acidic degradation as reported by Shu
et al. (2002) starting from a biotechnological HA sodium salt, Mw
1500 kDa that has been a generous gift from Novagenit s.r.l. (Italy).
Briefly, 2 g of HA were dissolved in 200 ml of twice distilled water
and the solution was kept in an orbital shaker incubator at 37 ◦C
overnight.
After this time, 4 ml of HCl 37% (w/v) were added and the solu-
tion was stirred with a blade stirrer for 5 min at 350 rpm. The
solution was kept in orbital shaker incubator at 37 ◦C for other 24 h
then the pH was adjusted to 7 with NaOH 1 N. The so obtained
solution was dialyzed against water for 5 days and the product was
recovered by freeze drying.
Since HA is not soluble in organic solvents, the tetrabutylamm-
onium salt of HA (HA-TBA) was produced as described in our
previous work (Palumbo et al., 2006).
1H NMR spectra were obtained with a Brucker AC-300 instru-
ment and by using D2O or D2O/NaOD as a solvent.
2.2. Synthesis of hyaluronic acid-ethylenediamine (HA-TBA-EDA)
derivative
HA-TBA-EDA was synthesized as reported in our previous work
(Palumbo et al., 2012).
Briefly, 500 mg of HA-TBA was dissolved in 45 ml of anhydrous
DMSO then a suitable amount of 4-NPBC, dissolved in 3 ml of DMSO,
was added dropwise to the HA-TBA solution at 40 ◦C (molar ratio
between 4-NPBC and HA-TBA equal to 0.75). The solution was left
at the same temperature for 4 h. After this time, ethylenediamine
(EDA) (molar ratio equal to 10 respect to the moles of 4-NPBC) was
added and the solution was left at 40 ◦C for 3 h. The obtained HA-
EDA-TBA derivative was precipitated in an excess of diethyl ether
then washed 4 times in acetone and dried under vacuum. For 1H
NMR characterization, to obtain a spectrum as clear as possible,
TBA was eliminated from the final product as follows: sample was
dissolved in water in the presence of 500 l of NaCl saturated aque-
ous solution, dialyzed against NaCl 5% (w/v) solution for 2 days and
then against water for other 2 days. The product was recovered by
freeze drying.
1H NMR spectrum of HA-EDA derivative in D2O showed princi-
pal peaks at ı1.9 (-NH-CO-CH3 of HA), ı3.1 (-CO-NH-CH2-CH2-NH2
of EDA), ı 3.3–3.8 (pyranosyl CH of HA).
The derivatization degree in terms of moles of EDA linked to HA
(DDEDA%), calculated by
1H NMR analysis, was 60±5 mol%.
2.3. Synthesis of HA-TBA-EDA-BMP macroinitiator
HA-TBA-EDA-BMP macroinitiator was synthesized according to
a procedure reported in our previous work (Pitarresi et al., 2013).
BMP carboxyl groups were activated with EDC and NHS in DMSO at
37 ◦C overnight, by using a molar ratio between activating agents
and BMP equal to 1.2. The obtained solution was added to a 1%
(w/v) solution of HA-TBA-EDA in anhydrous DMSO, in the presence
of DEA as a catalyst (molar ratio between DEA and amino groups of
HA-TBA-EDA equal to 1). The molar ratio between activated BMP
and HA-TBA-EDA amino groups was 1.8.
The reaction was carried out for 24 h at 40 ◦C, the product was
isolated by precipitation in acetone, purified by several washings
in the same solvent and recovered after drying under vacuum, then
characterized by 1H NMR analysis.
To obtain a spectrum as clear as possible, TBA was eliminated
from the final product (HA-TBA-EDA-BMP) as described in the pre-
vious paragraph.
1H NMR spectrum of HA-EDA-BMP derivative in D2O showed
principal peaks at ı 1.8 (-C(CH3)2-Br of BMP), ı 1.9 (-NH-CO-CH3
of HA), ı 3.1 (-CO-NH-CH2-CH2-NH2 of EDA), ı 3.3–3.8 (pyranosyl
CH of HA).
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2.4. Synthesis of HA-EDA-BMP-MANa copolymer through ATRP
50 mg of HA-TBA-EDA-BMP were dissolved in 5 ml of twice dis-
tilled water, then MANa was added in order to obtain a molar ratio
between vinyl monomer and BMP present in the macroinitiator
equal to 100.
The resultant solution was kept under Argon bubbling, until the
catalyst solution (obtained by dissolving Bpy and CuBr with a molar
ratio of 4:1 in anhydrous DMF) was added. The molar ratio between
CuBr and BMP groups present in HA-TBA-EDA-BMP was 2.
The reaction solution was sealed under Argon atmosphere for
24 h at 37 ◦C in orbital shaker incubator. Reaction was then stopped
by keeping reaction mixture in contact with air oxygen until the
complete oxidation of copper. The reaction mixture was dialyzed
(12–14 kDa cut-off) against NaCl 5% (w/v) solution for 2 days and
then against water for other 2 days, to eliminate the TBA, Cu++,
Bpy and the unreacted MANa. The product was recovered by freeze
drying and characterized by 1H NMR analysis and size exclusion
chromatography (SEC). The final yield ranged from 130% to 145%
compared to the initial weight of the macroinitiator.
1H NMR spectrum of HA-EDA-BMP-MANa derivative in
D2O/NaOD showed principal peaks at ı 0.6 (-C(CH3)2-Br of BMP;
-CH2-C(CH3)- of MANa), ı 1.3 (-CH2-C(CH3)- of MANa), ı 1.6 (-NH-
CO-CH3 of HA), ı 2.8–3.6 (pyranosyl CH of HA).
2.5. Turbidimetric analysis
In order to determine pH value that causes precipitation of HA-
EDA-BMP-MANa, a turbidimetric analysis has been performed on
solutions of HA-EDA-BMP-MANa dissolved in buffer solutions with
different pH values.
In particular, 900 l of buffer solution at different pH values (7.4,
5.5, 4.5, 3.5 and 2.5) were added to 100 l of a solution of HA-EDA-
BMP-MANa 1% (w/v) in ultrafiltered water. The transmittance of
the resulting mixtures was read at the wavelength of 500 nm using
a spectrophotometer UV-2401PC SHIMADZU. The analysis has been
performed in triplicate.
2.6. SEC characterization
Weight-average molecular weight (Mw) and polydispersity
index (Mw/Mn) of starting HA-EDA, and its derivatives here pre-
pared were determined by a SEC apparatus equipped with a pump
system (Waters 600, Mildford, MA, USA), a Universal column (par-
ticle size 5 m) and a 410 differential refractometer (DRI) as a
concentration detector (Waters 2410, Mildford, MA, USA).
Employed conditions were: 200 mM phosphate buffer (pH
6.5):MeOH 90:10 (v/v) as a mobile phase, 36±0.1 ◦C, flow rate
0.6 ml/min. The calibration curve was determined by using Pullulan
standards from Hyalose (USA) as reported by Ferguson et al. (2010).
In order to determine whether the treatment at pH 1 causes
polymer degradation, a SEC analysis has been also performed on
HA-EDA-BMP-MANa after 2 h of incubation at 37 ◦C in HCl 0.1 N.
The precipitated product was recovered by centrifugation, freeze-
dried and dissolved in the mobile phase for SEC analysis. HA-EDA
has been used as a control; it has been dissolved in HCl 0.1 N and
incubated for 2 h at 37 ◦C. After this time, the pH has been increased
to 5, the product has been freeze-dried and dissolved in the mobile
phase for SEC analysis. The analysis has been performed in tripli-
cate.
2.7. Incorporation and activity evaluation of ˛-chymotrypsin
-Chymotrypsin has been dissolved in TRIS buffer at pH 7.8 at a
concentration of 5 mg/ml, 450 l of the obtained solution was used
to dissolve 18 mg of HA-EDA-BMP-MANa or HA-EDA (weight ratio
between copolymer and enzyme 8:1) at 37 ◦C under gentle stirring.
The obtained copolymer/enzyme solution was freeze-dried.
The freeze-dried solid was treated with in 30 ml of HCl 0.1 M (pH
1) for 2 h at 37 ◦C (simulated gastric conditions), recovered by fil-
tration and dissolved in 30 ml of HCl 0.001 M (pH 3.0). The activity
of -chymotrypsin has been determined by using BTEE as a sub-
strate following supplier instruction. In particular, 100 l of the
obtained solution was mixed with 1.4 ml of BTEE solution (obtained
by dissolving 37 mg of BTEE in 63.4 ml of methanol and diluting to
a volume of 100 ml with ultra filtered water), 1.42 ml of TRIS pH 7.8
and 80 l of a 2 mM of CaCl2 solution.
Free freeze-dried -chymotrypsin treated at pH 7.8 for 2 h
has been used as a positive control, whereas free freeze-dried -
chymotrypsin treated at pH 1 for 2 h has been used as a negative
control.
As the assay with BTEE allows to determine only the amount of
active enzyme, to evaluate the total amount of protein entrapped
by HA-EDA-BMP-MANa, a HPLC-SEC analysis has been performed
by using a HPLC instrument Agilent 1100 equipped with a UV
detector and a SEC column Phenogel, 200 mM phosphate buffer
(pH 6.5):MeOH 90:10 (v/v) as a mobile phase, 36±0.1 ◦C, flow
rate 0.6 ml/min and a  of 281 nm. -Chymotrypsin dissolved in
TRIS buffer at pH 7.8 has been used for calibration curve (range of
concentration 0.25–1.5 mg/ml; y = 2411.7x−182.32; R2 = 0.9938).
2.8. Isolation of murine dermal fibroblasts and cell compatibility
studies
Rat fibroblasts (wistar rats) have been isolated as follows: der-
mis has been accurately shaved, cut into 1 cm2 pieces and immersed
in sterile PBS with 1% (v/v) of penicillin/streptomycin solution.
Specimens have been treated with an aqueous cold ethanol solu-
tion (70%, v/v) for 2 min, washed several times with sterile PBS and
reduced in small pieces with a scalpel. So obtained pieces have
been incubated with a Dispase II solution (2.5 U ml−1) for 1 h, then
the epidermis has been separated from the dermis with the use of
forceps.
Dermis pieces have been kept in the bottom of T-75 culture
flask for 1 h prior to add DMEM supplemented with FBS (10%, v/v),
penicillin–streptomycin solution (1%, v/v), glutamine solution (1%,
v/v) and amphotericin B solution (0.25%, v/v).
Specimens have been cultured for 2 weeks by changing the cul-
ture medium every two days until fibroblasts migrate from the
dermis to the culture flask. The so obtained cells have been cultured
from passage 1 to 7.
For cell compatibility studies, HA-EDA-BMP-MANa has been
sterilized as a powder by UV irradiation for 1 h by using a 125
watt UV-lamp and dissolved in supplemented DMEM at 0.1 and
0.5 mg/ml. Cells (1×105) have been seeded in each well of a 96 well
plate for 24 h and then the medium has been changed with each HA-
EDA-BMP-MANa solution (0.1 or 0.5 mg/ml). Cell viability has been
evaluated after 24 and 48 h of contact with the polymer through
MTS test by following the supplier instructions. Cell morphology
has been investigated by optical microscope Motic AE21.
Cells incubated in supplemented DMEM in the absence of poly-
mer, have been used as a positive control. Each experiment has
been performed in triplicate.
3. Results and discussion
3.1. Synthesis of HA-TBA-EDA-BMP macroinitiator
Following a procedure patented by our research group, we have
performed the derivatization of primary hydroxyl groups of HA
(in the form of TBA salt) with ethylenediamine (EDA) (Giammona
Author's personal copy
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Fig. 1. 1H NMR spectrum of HA-EDA in D2O.
et al., 2010) and we have already shown the importance, in terms of
increased reactivity for nucleophilic attack reactions, of including
free amino groups in HA (Palumbo et al., 2012).
Now, the nucleophilic character of primary amino groups of
EDA linked to HA (greater than primary hydroxyl groups of native
polysaccharide) has been exploited to link an alkyl halide bearing
molecule, like BMP, able to trigger, in the presence of an appropriate
catalyst system, ATRP process of sodium methacrylate (MANa).
In a previous work, by using a molar ratio between EDA and
repeating units of HA-TBA equal to 0.50, we have obtained a
HA-EDA derivative with a functionalization in EDA of 50 mol%
that subsequently has been derivatized with BMP (45±5 mol%)
(Pitarresi et al., 2013).
Here, to increase the amount of EDA linked to HA-EDA and in
order to increase also the amount of BMP linked to EDA groups,
we have chosen a molar ratio between EDA and repeating units of
HA-TBA equal to 0.75 (see Section 2).
Fig. 1 shows the 1H NMR spectrum of HA-EDA in D2O
which allowed to calculate the degree of functionalization in
EDA.
In particular, comparing the integral of the peak atı1.9 (arrow 1)
assigned to protons of CH3 belonging to N-acetyl-d-glucosamine
portion of HA with the integral of the peak at ı 3.1 (arrow 2)
assigned to one CH2 belonging to EDA residues linked to HA,
it was possible calculate a functionalization degree in EDA linked
to HA equal to 60±5 mol%.
This copolymer, as TBA salt, has been used for the reaction with
BMP in order to prepare the macroinitiator.
First, BMP carboxyl groups have been activated with EDC and
NHS in DMSO at 37 ◦C overnight, by using a molar ratio between
activating agents and BMP equal to 1.2. Then, the obtained solution
has been added to a 1% (w/v) solution of HA-TBA-EDA in anhy-
drous DMSO, in the presence of DEA as a catalyst; the molar ratio
between activated BMP and HA-TBA-EDA amino groups has been
1.8.
After appropriate purification, the copolymer HA-EDA-BMP has
been characterized by 1H NMR analysis (see Fig. 2) that, thanks to
the appearance of the peak at ı 1.8 (arrow 3) assigned to protons
of CH3 belonging to BMP, allowed to calculate a functionaliza-
tion in BMP equal to 55±5 mol%. This means that almost all free
amino groups of starting HA-EDA have been functionalized with
BMP thus obtaining an optimal macroinitiator to be used for ATRP
process.
3.2. Synthesis of HA-EDA-BMP-MANa copolymer through ATRP
In order to introduce carboxyl pendant groups on HA chains to
confer a pH sensitive behavior, HA-TBA-EDA-BMP has been used as
multifunctional macroinitiator for the polymerization of MANa via
ATRP. The molar ratio between MANa and alkyl bromide moieties
in HA-TBA-EDA-BMP has been 100.
ATRP has been performed in aqueous environment by using a
DMF solution of Bpy and CuBr (molar ratio of 4:1) as a catalyst. The
molar ratio between CuBr and BMP groups present in HA-TBA-EDA-
BMP was set to 2. The catalyst allows the homolytic cleavage of the
C-Br bond in BMP linked to HA thus producing a free radical able to
trigger the polymerization of MANa. After 24 h, reaction has been
Fig. 2. 1H NMR spectrum of HA-EDA-BMP in D2O.
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Fig. 3. 1H NMR spectrum of HA-EDA-BMP-MANa in D2O/NaDO.
stopped by simple contact with air oxygen until complete oxida-
tion of copper. The purification of the obtained product has been
performed by dialysis against NaCl solution to eliminate the
TBA and then against water to eliminate the unreacted sodium
methacrylate and exhausted catalyst.
The obtained product, named HA-EDA-BMP-MANa, has been
characterized by 1H NMR analysis to determine derivatization
degree in MANa linked to starting macroinitiator (DDMANa %)
(Fig. 3).
Since at the concentration usually employed for NMR analysis
in D2O, HA-EDA-BMP-MANa gives rise to a very viscous solu-
tion, in order to obtain a spectrum easily interpretable, 0.01 N
NaOD in D2O has been used as a solvent. We have observed that
this solvent allows to obtain a solution less viscous and there-
fore more easily usable for the analysis, even if peaks undergo a
shift toward higher fields. Indeed, as it can be seen in Fig. 3, the
peak assigned to protons of -NH-CO-CH3 of HA appears at ı 1.6
(arrow 4) instead of ı 1.9. There is also the appearance of a peak
at ı 0.6 (arrow 6) attributable to -C(CH3)2-Br of BMP and -CH2-
C(CH3)- of MANa, that shift their signals after the polymerization
process (Pitarresi et al., 2013). Finally, there is the appearance of
a peak at ı 1.3 (arrow 5) attributable to -CH2-C(CH3)- of MANa
formed after cleavage of the double bond during polymerization
process.
By comparing the integrals of these peaks, it was possible to
calculate the derivatization degree in MANa molecules linked to
HA-EDA-BMP that resulted to be 125±2 mol%.
The extension of polymerization process of MANa has been
expressed by means of the average polymerization number, “n”
calculated as:
n average = derivatization degree in methacrylic acid/
derivatization degree in BMP
Fig. 5. Values of % of transmittance (T%) at 500 nm as a function of the pH of con-
taining HA-EDA-BMP-MANa aqueous solutions.
Since as discussed in the previous paragraph the derivatization
in BMP molecules was 55±5 mol%, the “n” average in the final
product was about 2.27; this means that the 55% of the repetitive
units in HA-EDA-BMP-MANa contains three carboxyl groups (one
native and two in side chains due to ATRP of MANa) instead of one
(see Fig. 4).
3.3. Turbidimetric analysis
Turbidimetric analysis of HA-EDA-BMP-MANa aqueous solu-
tions with pH ranging from 7.4 to 2.5 has been used to demonstrate
the aggregation that occurs in acidic medium as a consequence
of protonation of carboxyl groups present in the copolymer. This
aggregation causes a precipitation of HA-EDA-BMP-MANa with for-
mation of solid particles able to decrease the transmittance of the
sample irradiated at 500 nm.
Fig. 5 shows the trend of the transmittance as a function of the
pH of containing HA-EDA-BMP-MANa aqueous solutions.
How it is possible to observe, the transmittance is close to 100%
for pH between 7.4 and 3 because the polymer is completely dis-
solved while when pH value is lowered below 3, transmittance
begins to decrease simultaneously with the precipitation of HA-
EDA-BMP-MANa. This precipitation is complete at pH lower than
2.5 when the formation of coarse particles produces a suspen-
sion (see image in Fig. 5). Therefore HA-EDA-BMP-MANa exhibits
a solubility pH dependent and the observed change in solubility is
reversible, indeed by raising the pH of the suspension to a value
higher than 2.5, the polymer is again soluble.
This pH sensitive behavior suggests a potential use of HA-
EDA-BMP-MANa as an innovative gastro-resistant excipient being
able to combine the physicochemical properties of typical gastro-
resistant polymers with the biological peculiarities of hyaluronic
acid.
Fig. 4. Chemical structure of HA-EDA-BMP-MANa.
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Table 1
Values of molecular weight (Mw) and polydispersity index (PDI), determined by SEC
chromatography, for HA-EDA and its obtained derivatives.
Sample Mw (kDa) PDI
HA-EDA 260 1.8
HA-EDA-BMP 279 1.3
HA-EDA-BMP-MANa 341 1.5
HA-EDA-BMP-MANa after 2 h at pH 1 335 1.4
HA-EDA after 2 h at pH 1 195 1.6
3.4. SEC characterization
SEC chromatography has been performed on all prepared HA-
EDA derivatives, to evaluate their molecular weight (Mw) and
polydispersity index (PDI). The values are reported in Table 1.
As expected, the molecular weight of HA-EDA-BMP-MANa is
greater than that of the other derivatives, thus confirming the suc-
cess of ATRP reaction. It is also interesting to observe that the
treatment at pH 1 for 2 h causes a decrease in molecular weight
of HA-EDA, indeed being soluble in this condition, its chains are
exposed to acid degradation. On the contrary HA-EDA-BMP-MANa
undergoes only a slight reduction in molecular weight; this result
suggests that the precipitation of HA-EDA-BMP-MANa at low pH
value, protects it from acidic degradation.
3.5. Incorporation and activity evaluation of ˛-chymotrypsin
In order to determine if HA-EDA-BMP-MANa derivative can
be exploited for the incorporation and protection of bioactive
molecules that usually are inactivated in the gastric environment,
-chymotrypsin has been chosen as a model of a protein molecule.
It is a proteolytic enzyme, degraded in acidic medium, indeed it is
physiologically secreted by the pancreas into the small intestine
and its optimal pH activity is between 7 and 9.
First as a negative control, we have evaluated the activity of free
-chymotrypsin in HCl 0.1 N at 37 ◦C as a function of time and how
it is possible to observe in Fig. 6, in simulated gastric environment,
there is a drastic decrease in its activity that comes almost zero
after 2 h, i.e. the average time of residence in the stomach.
Therefore, our aim has been to investigate if at low pH values,
HA-EDA-BMP-MANa is able to retain the enzyme protecting it from
the acid degradation, thus preserving its activity.
Fig. 6. Percentage of activity of free -chymotrypsin at pH 1 and 37 ◦C as a function
of time.
For this reason, -chymotrypsin has been dissolved in TRIS
buffer pH 7.8 and this solution has been used to dissolve HA-EDA-
BMP-MANa; the resulting solution has been freeze-dried to obtain
a solid that can be stored at −20 ◦C until use.
To mimic the gastric conditions, the freeze-dried poly-
mer/enzyme solid has been kept in HCl 0.1 N for 2 h at 37 ◦C under
gentle stirring, then to evaluate if the potentially incorporated
enzyme is still active, the solid has been recovered by filtration,
dissolved in HCl 0.001 N and tested at pH 7.8 through BTEE assay,
chosen as a specific substrate for -chymotrypsin (see Scheme 1).
By evaluating the increase in absorbance at 256 nm of a solution
containing the enzyme and the substrate BTEE, as a function of time,
it is possible to determine the amount of active -chymotrypsin
expressed as active units per ml.
Fig. 7 shows the percentage of enzymatic activity determined
by BTEE assay.
How it is possible to observe, the activity of the enzyme
entrapped by HA-EDA-BMP-MANa is 79±4% respect to the positive
control, i.e. a solution of free -chymotrypsin incubated for 2 h at
Scheme 1. Schematic representation of procedure adopted to determine by BTEE assay the activity of -chymotrypsin in the presence of HA-EDA-BMP-MANa after treatment
in simulated gastric conditions.
Author's personal copy
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Fig. 7. Percentage of activity of -chymotrypsin in the presence of HA-EDA-BMP-MANa or HA-EDA after treatment at pH 1 for 2 h. Positive and negative controls are also
shown.
pH 7.8, whereas enzyme alone (negative control) or in the presence
of HA-EDA and incubated for 2 h at pH 1 is almost inactive.
Since enzyme activity in the presence of HA-EDA-BMP-MANa
is less than 100%, it could be supposed that -chymotrypsin has
lost part of its activity or that an amount of enzyme is released
in the medium during the incubation at pH 1. On the other hand,
the assay with BTEE allows to evaluate only the amount of active
enzyme, and not the total amount of protein entrapped by HA-
EDA-BMP-MANa. Therefore, in order to determine the total amount
of enzyme that remains entrapped by HA-EDA-BMP-MANa after
2 h at pH 1, a HPLC-SEC analysis has been performed (see Sec-
tion 2). Since the value found by HPLC-SEC analysis corresponds
to 78% of starting amount of enzyme, according to the value
obtained with BTEE assay, this result confirms that all entrapped
enzyme maintains its activity thanks to the protection due to
HA-EDA-BMP-MANa.
3.6. Cell compatibility studies
Cell compatibility has been evaluated by performing a MTS assay
on murine dermal fibroblasts, chosen as model cells, in contact with
HA-EDA-BMP-MANa. In particular, HA-EDA-BMP-MANa has been
kept in direct contact for 24 and 48 h with cells by dissolving it in
the culture medium at a concentration equal to 0.1 and 0.5 mg/ml.
Results shown in Fig. 8A shows that cell viability is not influenced by
the presence of HA-EDA-BMP-MANa for both investigated polymer
concentrations and contact times, thus demonstrating that chemi-
cal modifications of HA, i.e. the derivatization with EDA, BMP and
Fig. 8. Viability, expressed as percentage of viable cells compared to the positive control (absorbance read at 492 nm, MTS assay) (A) and optical images (B) of murine dermal
fibroblasts after 24 and 48 h of contact with a solution of HA-EDA-BMP-MANa at 0.1 and 0.5 mg/ml.
Author's personal copy
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final ATRP of MANa have not modified cell compatibility of starting
polysaccharide.
Besides viability, also cell morphology does not undergo alter-
ation indeed it is evident the spindle like shape of fibroblasts like
the positive control (see images in Fig. 8B).
4. Conclusions
A new pH sensitive derivative of hyaluronic acid has been pro-
duced by ATRP. By exploiting free amino groups of HA-EDA, through
a simple and reproducible chemistry, we have obtained a macroini-
tiator (HA-EDA-BMP) able to trigger the polymerization of sodium
methacrylate (MANa) via ATRP process.
The obtained HA-EDA-BMP-MANa showed a pronounced pH
sensitive behavior, indeed thanks to the presence of carboxyl
groups introduced with MANa, it is able to precipitate in a reversible
manner at pH below 2.5. This property has been exploited for the
incorporation of -chymotrypsin, chosen as an example of protein
molecule inactivated in acid medium.
We have demonstrated that HA-EDA-BMP-MANa is able to
entrap the enzyme and to preserve its activity in simulated gas-
tric conditions. It has also been observed that HA-EDA-BMP-MANa
does not affect the viability of murine dermal fibroblasts, chosen
as model cells, thus demonstrating the cell compatibility of the
polymer itself.
Thanks to these characteristics, HA-EDA-BMP-MANa appears as
an interesting material for the production of micro or nano oral
drug delivery systems that could combine pH sensitivity with bio-
logical properties of HA, like interaction with CD44 receptors over
expressed by colon tumoral cells.
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